M MLTX
MoonLake Immunotherapeutics - Class A
$12.35
-0.88% ($0.11)
Volume
2.30M
52W High
$62.75
52W Low
$5.95
Market Cap
$1.46B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$0.77
Whisper EPS
-$0.77
0.3% above consensus
Last Quarter
-$0.87
Current Streak
3 Beats
Avg Surprise (4Q)
+2.54%
Next Earnings Report
Reports in 46 days
Price Chart
EPS History: Consensus vs Actual
Last 10 quartersPrice Movement Around Earnings
Q2 2026
Aug 11, 2026
1-Day:
+3.86%
Q2 2026
Aug 10, 2026
1-Day:
-4.27%
Q2 2026
Aug 6, 2026
1-Day:
+1.28%
5-Day:
-7.99%
Q2 2026
Aug 5, 2026
1-Day:
+2.74%
5-Day:
-1.25%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'24 | $101,850 | -- | 50.0% | -10,000.0% | -$45.6M |
| Q1'24 | $19,738 | -- | -115.6% | -10,000.0% | -$13.7M |
| Q4'23 | $19,738 | -- | 83.3% | -10,000.0% | -$7.4M |
Company Information
Symbol
MLTX
Company
MoonLake Immunotherapeutics - Class A
Market Cap
$1.46B
Next Earnings
Nov 4, 2026